BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38633762)

  • 21. Hypogonadism and Cryptorchidism.
    Rodprasert W; Virtanen HE; Mäkelä JA; Toppari J
    Front Endocrinol (Lausanne); 2019; 10():906. PubMed ID: 32010061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up.
    Preiksa RT; Zilaitiene B; Matulevicius V; Skakkebaek NE; Petersen JH; Jørgensen N; Toppari J
    Hum Reprod; 2005 Jul; 20(7):1928-32. PubMed ID: 15860495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of congenital cryptorchidism in Estonia.
    Kübarsepp V; Varik K; Varendi H; Antson A; Veinla M; Nellis G; Merila M; Salundi U; Astover V; Punab M
    Andrology; 2022 Feb; 10(2):303-309. PubMed ID: 34699126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors controlling testis descent.
    Hughes IA; Acerini CL
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S75-82. PubMed ID: 18647820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal serum concentrations of bisphenol A and propyl paraben in early pregnancy are associated with male infant genital development.
    Fisher BG; Thankamony A; Mendiola J; Petry CJ; Frederiksen H; Andersson AM; Juul A; Ong KK; Dunger DB; Hughes IA; Acerini CL
    Hum Reprod; 2020 Apr; 35(4):913-928. PubMed ID: 32325494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal paracetamol exposure is associated with shorter anogenital distance in male infants.
    Fisher BG; Thankamony A; Hughes IA; Ong KK; Dunger DB; Acerini CL
    Hum Reprod; 2016 Nov; 31(11):2642-2650. PubMed ID: 27609981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of boys with the so-called true undescended testis diagnosed at the third postnatal month--a population-based case-control study.
    Mavrogenis S; Urbán R; Czeizel AE
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1152-7. PubMed ID: 25053192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptorchidism --disease or symptom?
    Toppari J; Rodprasert W; Virtanen HE
    Ann Endocrinol (Paris); 2014 May; 75(2):72-6. PubMed ID: 24786701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between exposure to perfluorinated compounds and congenital cryptorchidism: a nested case-control study among 215 boys from Denmark and Finland.
    Vesterholm Jensen D; Christensen J; Virtanen HE; Skakkebæk NE; Main KM; Toppari J; Veje CW; Andersson AM; Nielsen F; Grandjean P; Jensen TK
    Reproduction; 2014; 147(4):411-7. PubMed ID: 24218628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The possible role of endocrine disrupting chemicals in the aetiology of cryptorchidism and hypospadias: a population-based case-control study in rural Sicily.
    Carbone P; Giordano F; Nori F; Mantovani A; Taruscio D; Lauria L; Figà-Talamanca I
    Int J Androl; 2007 Feb; 30(1):3-13. PubMed ID: 16824044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental factors and testicular function.
    Giwercman A; Giwercman YL
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):391-402. PubMed ID: 21397206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic, Maternal, and Environmental Risk Factors for Cryptorchidism: An Update.
    Barthold JS; Reinhardt S; Thorup J
    Eur J Pediatr Surg; 2016 Oct; 26(5):399-408. PubMed ID: 27642851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine disruptors and testicular function.
    Lymperi S; Giwercman A
    Metabolism; 2018 Sep; 86():79-90. PubMed ID: 29605435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.
    Virtanen HE; Rajpert-De Meyts E; Main KM; Skakkebaek NE; Toppari J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):501-5. PubMed ID: 16005920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and pathogenesis of cryptorchidism.
    Virtanen HE; Toppari J
    Hum Reprod Update; 2008; 14(1):49-58. PubMed ID: 18032558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnic patterns of hypospadias in New Zealand do not resemble those observed for cryptorchidism and testicular cancer: evidence of differential aetiology?
    Gurney JK; Stanley J; Shaw C; Sarfati D
    Andrology; 2016 Jan; 4(1):82-6. PubMed ID: 26566182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment and follow up on undescended testis.
    Thorup J; Cortes D
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):38-43. PubMed ID: 19696715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of reproductive disorders and male congenital anomalies with environmental exposure to endocrine active pesticides.
    García J; Ventura MI; Requena M; Hernández AF; Parrón T; Alarcón R
    Reprod Toxicol; 2017 Aug; 71():95-100. PubMed ID: 28479404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time and spatial trends of operated cryptorchidism in France and environmental hypotheses: a nationwide study from 2002 to 2014.
    Le Moal J; Goria S; Guillet A; Rigou A; Chesneau J
    Hum Reprod; 2021 Apr; 36(5):1383-1394. PubMed ID: 33728432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupational exposure to endocrine-disrupting chemicals and other parental risk factors in hypospadias and cryptorchidism development: a case-control study.
    Estors Sastre B; Campillo Artero C; González Ruiz Y; Fernández Atuan RL; Bragagnini Rodríguez P; Frontera Juan G; Gracia Romero J
    J Pediatr Urol; 2019 Oct; 15(5):520.e1-520.e8. PubMed ID: 31405798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.